News

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

July 24, 2020 signalgroup

Trump Administration’s Drug Plan Must Include Biosimilars to Lower Costs for Seniors and Medicare

July 14, 2020 signalgroup

ICYMI: House Appropriators Encourage CMS to Support Biosimilars; Experts Point to Biosimilars to Help Lower Drug Costs, Call on Congress and Administration to Act

July 1, 2020 signalgroup

The Biosimilars Forum Applauds Senators Cornyn and Bennet’s Introduction of Legislation to Lower Health Costs by Supporting Biosimilars

June 22, 2020 signalgroup

The Biosimilars Forum To Provide Comment at FDA’s Annual Meeting on the Biosimilar User Fee Program

May 28, 2020 signalgroup

Bringing Down Federal Spending: A Biosimilars Shared Savings Model To Lower Health Care Costs

May 27, 2020 signalgroup

Robust Biosimilars Market Could Save U.S. Taxpayers $7 Billion Annually, New Analysis Finds

May 21, 2020 signalgroup

AMA: U.S. Health Insurance Plans Prefer Brand Biologics Twice as Often as Lower-Cost Biosimilars

April 30, 2020 signalgroup

ICYMI: After Congress Approved $3 Trillion in Spending Amid the COVID-19 Pandemic, Biosimilars Can Reduce Health Care Costs for Employers and the U.S. Health Care System

April 27, 2020 signalgroup

ICYMI: Expert Encourage Increasing Biosimilar Use to Lower Health Care Costs; Study Finds Biosimilars Could Lower Employers Insurance Costs

March 31, 2020 signalgroup

Self-Insured Employers Could Have Saved Up to $1.4 Billion in 2018 with Lower-Cost Biosimilars